Showing results (61-70 of 421) with videos related to
Sort By:
Pageof 43
The New England Journal of Medicine|June 27, 1985
Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotypeM Raffeld, L Neckers, D L Longo, et al.Cancer|October 15, 1987
Biologic therapy for the treatment of malignant common epithelial tumors of the ovaryT C Hamilton, R F Ozols, D L LongoCancer|February 1, 1987
Current and future uses of recombinant interferon alpha in the treatment of low-grade non-Hodgkin's lymphomaR G Steis, K A Foon, D L LongoJournal of the National Cancer Institute. Monographs|January 1, 1990
Late complications of Hodgkin's disease managementR C Young, M A Bookman, D L LongoBiochemical and Biophysical Research Communications|October 4, 1995
Inactivation of NF-kappa B inhibitor I kappa B alpha: ubiquitin-dependent proteolysis and its degradation productC C Li, R M Dai, D L LongoSeminars in Immunology|August 1, 1996
The huPBL-SCID mouse as a means to examine human immune function in vivoW J Murphy, D D Taub, D L LongoJournal of Immunology (Baltimore, Md. : 1950)|April 1, 1995
A novel phosphocholine antigen protects both normal and X-linked immune deficient mice against Streptococcus pneumoniae. Comparison of the 6-O-phosphocholine hydroxyhexanoate-conjugate with other phosphocholine-containing vaccinesR T Fischer, D L Longo, J J KennyThe Journal of Experimental Medicine|July 1, 1993
Differential effects of growth hormone and prolactin on murine T cell development and functionW J Murphy, S K Durum, D L LongoBlood|February 15, 1996
Human interferon-inducible protein-10 induces mononuclear cell infiltration in mice and promotes the migration of human T lymphocytes into the peripheral tissues and human peripheral blood lymphocytes-SCID miceD D Taub, D L Longo, W J MurphyCancer Treatment Reports|September 1, 1985
Deep venous thrombosis during therapy for Hodgkin's diseaseE J Seifter, R C Young, D L LongoPageof 43